Filtered By:
Cancer: Leukemia

This page shows you your search results in order of date. This is page number 12.

Order by Relevance | Date

Total 341 results found since Jan 2013.

Is Nuclear DNA Damage Responsible for Stem Cell Aging?
Researchers here cast doubt on nuclear DNA damage as a primary cause of decline in the stem cell population that is responsible for creating immune cells and blood cells. All cell populations accumulate random mutations in nuclear DNA over the course of aging. It is well proven that this causes a rise in cancer risk, though as noted in the paper here that isn't a simple linear relationship. The consensus position is that this damage also contributes to degenerative aging in the form of increased disarray in cell operations, but there is no solid evidence to demonstrate that this is in fact so, nor to show the degree to whi...
Source: Fight Aging! - July 14, 2016 Category: Research Authors: Reason Tags: Daily News Source Type: blogs

Chimeric Antigen Receptor Strategies can be Used to Target and Destroy Specific Classes of Unwanted Immune Cell
The work noted here is targeted at curing autoimmune conditions by removing the misconfigured immune cells that attack important infrastructure in tissues. This is good news for all autoimmunity in which the relevant biochemistry is fairly well understood - where the target immune cells can be well described in terms of their distinctive surface chemistry. However this is also very good news for the prospects of rejuvenating the aged adaptive immune system, wherein much of the problem is that the available capacity for immune cells is used up by an excess of cells uselessly specific to persistent viruses such as cytomegalo...
Source: Fight Aging! - July 1, 2016 Category: Research Authors: Reason Tags: Daily News Source Type: blogs

Watch this inspiring cancer rap from a doctor diagnosed with leukemia
x Props to Elana Miller at Zen Psychiatry.  Truly inspiring. Your patients are rating you online: How to respond. Manage your online reputation: A social media guide. Find out how.
Source: Kevin, M.D. - Medical Weblog - June 29, 2016 Category: Journals (General) Authors: Tags: Video Cancer Source Type: blogs

Fight Aging! Newsletter, June 27th 2016
In conclusion, we showed for the first time that 7-KC induces oxidative stress via lysosomal dysfunction, resulting in exacerbation of calcification. CHIMERIC ANTIGEN RECEPTOR CANCER THERAPIES CAN NOW TARGET SOLID TUMORS https://www.fightaging.org/archives/2016/06/chimeric-antigen-receptor-cancer-therapies-can-now-target-solid-tumors/ If the research community is to win in the fight to cure cancer, and win soon enough to matter for all of us, then the focus must be on technology platforms that can be easily and cheaply adapted to many different types of cancer. The biggest strategic problem in the field is tha...
Source: Fight Aging! - June 26, 2016 Category: Research Authors: Reason Tags: Newsletters Source Type: blogs

Chimeric Antigen Receptor Cancer Therapies Can Now Target Solid Tumors
If the research community is to win in the fight to cure cancer, and win soon enough to matter for all of us, then the focus must be on technology platforms that can be easily and cheaply adapted to many different types of cancer. The biggest strategic problem in the field is that most of the expensive, time-consuming efforts to develop new therapies are only applicable to one or a few of the hundreds of types of cancer. Immunotherapies based on the use of chimeric antigen receptors are an incremental step towards solving this problem, an improvement on the present situation because this technology may cut the cost of tail...
Source: Fight Aging! - June 22, 2016 Category: Research Authors: Reason Tags: Daily News Source Type: blogs

Fight Aging! Newsletter, June 13th 2016
FIGHT AGING! NEWSLETTER June 13th 2016 Fight Aging! provides a weekly digest of news and commentary for thousands of subscribers interested in the latest longevity science: progress towards the medical control of aging in order to prevent age-related frailty, suffering, and disease, as well as improvements in the present understanding of what works and what doesn't work when it comes to extending healthy life. Expect to see summaries of recent advances in medical research, news from the scientific community, advocacy and fundraising initiatives to help speed work on the repair and reversal of aging, links to on...
Source: Fight Aging! - June 12, 2016 Category: Research Authors: Reason Tags: Newsletters Source Type: blogs

Partnering to Help Survivors Address Financial Hardships
Cancer care has come a long way in recent years, with breakthroughs and advancements in areas such surgery, radiology, symptom management, chemotherapy and immunotherapy. However, in many cases, these advancements have also increased the cost and complexity of care. For example, patients are now paying higher insurance premiums, deductibles, coinsurance and co-payments. The rise in care costs has created a new side effect for cancer patients– financial toxicity(1). This term refers to the negative impact the cost of cancer care can have on the patient’s financial circumstances such as their ability to pay for medical b...
Source: LIVESTRONG Blog - June 9, 2016 Category: Cancer & Oncology Authors: Guest Source Type: blogs

You Ought to Have a Look: A Shout-Out to Lukewarming, a Look at the Republic of Science and a “Roundup” of EPA and Glyphosate
You Ought to Have a Look is a feature from the Center for the Study of Science posted by Patrick J. Michaels and Paul C. (“Chip”) Knappenberger.  While this section will feature all of the areas of interest that we are emphasizing, the prominence of the climate issue is driving a tremendous amount of web traffic.  Here we post a few of the best in recent days, along with our color commentary. — We’ve put together an interesting collection of articles this week for your consideration. First up is a shout out to lukewarming from Bloomberg View columnist Megan McArdle. In her piece “Global Warming Alarmists, You...
Source: Cato-at-liberty - June 6, 2016 Category: American Health Authors: Patrick J. Michaels, Paul C. "Chip" Knappenberger Source Type: blogs

My Greatest Professional Accomplishment Was a Bureaucratic Miracle
When we achieve our all-time greatest professional accomplishment, we know it right away. Like Dr. Carl June developing a novel way to treat cancer, Mark Sanchez not throwing an interception, and me breaking through bureaucracy in the U.S. federal government to author a column in my organization's 18,000-circulation newsletter.Last summer, the communications office where I work wanted to create a new feature in our newsletter focusing on a different employee every other week. They asked me to write it. They said, "We want it to be about people's day-to-day lives at work."I said, "That's boring, how about instead I intervie...
Source: cancerslayerblog - May 9, 2016 Category: Cancer & Oncology Tags: writing/speaking Source Type: blogs

Why I Became a Cancer Advocate: Amy
by Amy Mattes, LIVESTRONG Leader Walking out of a friend’s funeral that had lost her battle with leukemia, and watching her three young daughters, husband, family and community grieving, felt very unnecessary. In addition, her twin sister had stage IV lymphoma.  I was forever changed that day. I vowed to use my experience and knowledge and advocate in the fight against cancer.   As a cancer registrar, I have witnessed almost every aspect of cancer. A very insightful aspect of my job has been participating on a multidisciplinary team of physicians, nurses, social workers, and pastoral care staff. We discuss our patient...
Source: LIVESTRONG Blog - May 7, 2016 Category: Cancer & Oncology Authors: LIVESTRONG Staff Source Type: blogs

Make a patient’s journey easier with a simple act of kindness
I’ve held many hands, been generous with my hugs, and tried to treat every patient as though they were my mother. I lost my mother to leukemia almost one decade ago. I know what it’s like to feel defeated by the health care system, by health care providers, by medications, and by the human body’s response to all of the above. A patient will never forget a health care provider that took the time to make sure they understood their health status. Sometimes the best medicine is being able to grasp exactly what is going on. A patient with a solid knowledge base does not have a chance to question death when dea...
Source: Kevin, M.D. - Medical Weblog - May 4, 2016 Category: Journals (General) Authors: Tags: Physician Cancer Source Type: blogs

Fight Aging! Newsletter, May 2nd 2016
This study is the first CAR T-cell trial to infuse patients with an even mixture of two types of T cells (helper and killer cells, which work together to kill cancer). With the assurance that each patient gets the same mixture of cells, the researchers were able to come to conclusions about the effects of administering different doses of cells. In 27 of 29 participants whose responses were evaluated a few weeks after the infusion, a high-sensitivity test could detect no trace of their cancer in their bone marrow. The CAR T cells eliminated cancers anywhere in the body they appeared. Of the two participants who did n...
Source: Fight Aging! - May 1, 2016 Category: Research Authors: Reason Tags: Newsletters Source Type: blogs

The Latest Results from a Trial of Chimeric Antigen Receptor Immunotherapy to Treat Cancer
This study is the first CAR T-cell trial to infuse patients with an even mixture of two types of T cells (helper and killer cells, which work together to kill cancer). With the assurance that each patient gets the same mixture of cells, the researchers were able to come to conclusions about the effects of administering different doses of cells. In 27 of 29 participants whose responses were evaluated a few weeks after the infusion, a high-sensitivity test could detect no trace of their cancer in their bone marrow. The CAR T cells eliminated cancers anywhere in the body they appeared. Of the two participants who did n...
Source: Fight Aging! - April 28, 2016 Category: Research Authors: Reason Tags: Daily News Source Type: blogs

Value Pricing For Drugs: Whose Value, What Price?
It is hard to read a newspaper these days without coming across a story about the high and ever increasing cost of drugs. The Wall Street Journal named drug prices the top health story of 2015. Stories about drug prices fall into two general categories. The first are stories about generic and other manufacturers who are not focused on innovation (like Turing Pharmaceuticals and Valeant) but who acquire generic drugs and increase the price dramatically without adding value while also making it impossible for competitors to manufacture the drug by controlling the distribution. While this problem is real, it is not the focus ...
Source: Health Affairs Blog - March 28, 2016 Category: Health Management Authors: Robert Rubin Tags: Costs and Spending Drugs and Medical Technology Featured Medicare ACOs Big Pharma cost effectiveness analysis high-cost drugs PCSK9 inhibitors QUALY value-based payment Source Type: blogs

Progress against cancer? Let's think about it.
It is difficult to pick up a newspaper these days without reading an article proclaiming progress in the field of cancer research. Here is an example, taken from an article posted on the MedicineNet site (1). The lead-off text is: "Statistics (released in 1997) show that cancer patients are living longer and even "beating" the disease. Information released at an AMA sponsored conference for science writers, showed that the death rate from the dreaded disease has decreased by three percent in the last few years. In the 1940s only one patient in four survived on the average. By the 1960s, that figure was up to one in three, ...
Source: Specified Life - March 25, 2016 Category: Information Technology Tags: cancer cancer cure cancer statistics cancer treatments orphan diseases progress in cancer research rare diseases Source Type: blogs